Literature DB >> 22335765

Symptom profile and risk factors of anaphylaxis in Central Europe.

M Worm1, G Edenharter, F Ruëff, K Scherer, C Pföhler, V Mahler, R Treudler, R Lang, K Nemat, A Koehli, B Niggemann, S Hompes.   

Abstract

BACKGROUND: Anaphylaxis is the most severe manifestation of an IgE-dependent allergy. Standardized acquired clinical data from large cohorts of well-defined cases are not available. The aim of this study was to analyse the symptom profile and risk factors of anaphylaxis in a large Central European cohort.
METHODS: We acquired data from patients in Germany, Austria and Switzerland who experienced a severe allergic reaction defined by the onset of severe pulmonary and/or severe cardiovascular symptoms. The data were gained via an online questionnaire from 83 medical centres specialized in allergy. Data were collected from 2006 to 2010 and analysed by using a multinomial regression model.
RESULTS: A total of 2012 paediatric and adult patients were included into the present analysis. The skin (84%) was the most frequently affected organ followed by the cardiovascular (72%) and the respiratory (68%) system. The regression model analysing the onset of cardiovascular versus respiratory symptoms revealed a strong impact of age (adjusted OR = 6.08; 95% CI, 3.35-11.01; P < 0.001). Furthermore, the elicitor food (adjusted OR = 0.29; 95% CI, 0.21-0.41, P < 0.001) and the presence of atopic diseases (adjusted OR = 0.54; 95% CI, 0.40-0.73, P < 0.001) were significantly associated with the onset of respiratory symptoms.
CONCLUSION: Data from individuals who experienced anaphylaxis can support the identification of risk factors. The present study indicates that age, the elicitor itself and the presence of atopic diseases have an impact on the symptom profile of anaphylaxis. Identifying further risk factors of anaphylaxis is of significant importance for clinical practice in the future.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22335765     DOI: 10.1111/j.1398-9995.2012.02795.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  42 in total

Review 1.  [Classification and pathophysiology of angioedema].

Authors:  T Buttgereit; M Maurer
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

Review 2.  [Epidemiology of anaphylaxis].

Authors:  M Worm
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

Review 3.  [Exercise-induced anaphylaxis].

Authors:  K Wylon; S Hompes; M Worm
Journal:  Hautarzt       Date:  2013-02       Impact factor: 0.751

4.  [Undesired cutaneous adverse drug reactions: What is new?].

Authors:  R Treudler; J C Simon
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

5.  Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report.

Authors:  Susan J Allen; Paul L Chazot; C Jane Dixon
Journal:  Br J Clin Pharmacol       Date:  2018-04-18       Impact factor: 4.335

Review 6.  Angioedema.

Authors:  Janina Hahn; Thomas K Hoffmann; Bastian Bock; Melanie Nordmann-Kleiner; Susanne Trainotti; Jens Greve
Journal:  Dtsch Arztebl Int       Date:  2017-07-24       Impact factor: 5.594

Review 7.  The pathophysiology of anaphylaxis.

Authors:  Laurent L Reber; Joseph D Hernandez; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

8.  Adrenaline in the Acute Treatment of Anaphylaxis.

Authors:  Johannes Ring; Ludger Klimek; Margitta Worm
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

Review 9.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

10.  Ovomucoid epitope-specific repertoire of IgE, IgG4 , IgG1 , IgA1 , and IgD antibodies in egg-allergic children.

Authors:  Maria Suprun; Robert Getts; Galina Grishina; Angela Tsuang; Mayte Suárez-Fariñas; Hugh A Sampson
Journal:  Allergy       Date:  2020-06-01       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.